Aclaris Therapeutics (NASDAQ:ACRS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Aclaris Therapeutics (ACRS) operate in?

Aclaris Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Aclaris Therapeutics Stock (NASDAQ: ACRS) stock price, news, charts, stock research, profile.

Open	$2.20
Close	$2.05
Volume / Avg.	736.03K / 562.73K
Day Range	$2.03 - $2.29
52 Wk Range	0.67 - 2.72
Market Cap	$146.43M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	4.02%
Days to Cover	2.16

Recent News

Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying

Avi Kapoor

Is ADMA Biologics Stock Outpacing Its Medical Peers This Year?

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Adma Biologics (NASDAQ: ADMA) one of those stocks right now?

Zacks

Aclaris Therapeutics And 1 Other Stock Under $5 Insiders Are Buying

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.20
Close	$2.05
Volume / Avg.	736.03K / 562.73K
Day Range	$2.03 - $2.29
52 Wk Range	0.67 - 2.72
Market Cap	$146.43M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	4.02%
Days to Cover	2.16

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aclaris Therapeutics (ACRS) stock?

You can purchase shares of Aclaris Therapeutics (NASDAQ:ACRS) through any online brokerage.

View our list of the best stock brokerages

Who are Aclaris Therapeutics (ACRS) competitors?

Other companies in Aclaris Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR), Telomir Pharmaceuticals (NASDAQ:TELO) and SIGA Technologies (NASDAQ:SIGA).

What is the forecast, or price target, for Aclaris Therapeutics (ACRS) stock?

Aclaris Therapeutics has a consensus price target of $14.67.

What is the current price for Aclaris Therapeutics (ACRS)?

The stock price for Aclaris Therapeutics (NASDAQ: ACRS) is $2.05 last updated November 15, 2024 at 4:20 PM EST.

Does Aclaris Therapeutics (ACRS) pay a dividend?

There are no upcoming dividends for Aclaris Therapeutics.

When is Aclaris Therapeutics (NASDAQ:ACRS) reporting earnings?

Aclaris Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.

Is Aclaris Therapeutics (ACRS) going to split?

There is no upcoming split for Aclaris Therapeutics.

What sector and industry does Aclaris Therapeutics (ACRS) operate in?

Aclaris Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Aclaris Therapeutics

Aclaris Therapeutics (ACRS) Forecast